Use of cbg gene as genetic marker of hypercortisolemia and related pathologies
CA 2465320 A1 · Owner: Institut National De La Recherche Agronomique (Inra) · Inventors: Milan, Denis; Bidanel, Jean-Pierre; Ousova, Olga
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention concerns a method for identifying polymorphous markers associated with the hypercortisolemia phenotype. The invention is characterized in that it consists in comparing nucleic acid sequences of several subjects comprising all or part of the Cbg gene and identifying mutations in the Cbg gene or the sequences adjacent thereto. The invention also concerns a polymorphous marker associated with the hypercortisolemia phenotype consisting of a nucleic acid sequence comprising all or part of the Cbg gene or adjacent 3' or 5' sequences preferably distant by not more than 100 kb.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 31, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 31, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 31, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.